CUSIP 738920115*W EXP 02/14/203ASBPWQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
29 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Saba Capital Management, L.P. | 983.6K | $19.3K | 0 | Held |
| 2 | Linden Advisors LP | 900.0K | $17.7K | 0 | Held |
| 3 | Adage Capital Partners Gp, L.L.C. | 1.05M | $17.3K | 0 | Held |
| 4 | Aristeia Capital, L.L.C. | 681.5K | $13.4K |
| 0 |
| Held |
| 5 | Sculptor Capital LP | 500.0K | $9.8K | 0 | Held |
| 6 | Toronto Dominion Bank | 516.4K | $8.3K | −500 | Reduced |
| 7 | Verition Fund Management LLC | 432.8K | $7.1K | 0 | Held |
| 8 | Barclays PLC | 350.0K | $5.8K | 0 | Held |
| 9 | Clear Street Group Inc. | 330.8K | $5.5K | −106.5K | Reduced |
| 10 | Antara Capital LP | 207.7K | $3.4K | 0 | Held |
See every fund holding Aspire Biopharma Hldgs Inc, with full quarter-over-quarter share changes.
Unlock all holders